.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Cerilliant
Novartis
US Army
McKinsey
QuintilesIMS
Moodys
Baxter
Fish and Richardson
UBS

Generated: December 14, 2017

DrugPatentWatch Database Preview

Patents Expiring in September 2029

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Cumberland PharmsCALDOLORibuprofenSOLUTION;INTRAVENOUS022348-002Jun 11, 2009RXYesYes► Subscribe► Subscribe► SubscribeMETHODS OF TREATING PAIN, INFLAMMATION AND/OR FEVER IN A CRITICALLY ILL PATIENT WITH INTRAVENOUS IBUPROFEN IN NEED THEREOF
Salix PharmsRELISTORmethylnaltrexone bromideSOLUTION;SUBCUTANEOUS021964-003Sep 27, 2010RXYesYes► Subscribe► Subscribe► SubscribeYTREATMENT OF OPIOID-INDUCED CONSTIPATION
Salix PharmsRELISTORmethylnaltrexone bromideSOLUTION;SUBCUTANEOUS021964-002Sep 27, 2010RXYesYes► Subscribe► Subscribe► SubscribeYTREATMENT OF OPIOID-INDUCED CONSTIPATION
Cumberland PharmsCALDOLORibuprofenSOLUTION;INTRAVENOUS022348-002Jun 11, 2009RXYesYes► Subscribe► Subscribe► Subscribe
Salix PharmsRELISTORmethylnaltrexone bromideSOLUTION;SUBCUTANEOUS021964-003Sep 27, 2010RXYesYes► Subscribe► Subscribe► SubscribeYTREATMENT OF OPIOID-INDUCED CONSTIPATION
Salix Pharms IncRELISTORmethylnaltrexone bromideTABLET;ORAL208271-001Jul 19, 2016RXYesYes► Subscribe► Subscribe► SubscribeYTREATMENT OF OPIOID-INDUCED CONSTIPATION
Salix PharmsRELISTORmethylnaltrexone bromideSOLUTION;SUBCUTANEOUS021964-002Sep 27, 2010RXYesYes► Subscribe► Subscribe► SubscribeYTREATMENT OF OPIOID-INDUCED CONSTIPATION
Cumberland PharmsCALDOLORibuprofenSOLUTION;INTRAVENOUS022348-002Jun 11, 2009RXYesYes► Subscribe► Subscribe► SubscribeMANAGEMENT OF MILD TO MODERATE PAIN, MANAGEMENT OF MODERATE TO SEVERE PAIN AS AN ADNUNCT TO OPIOID ANALGESICS, REDUCTION IN FEVER THROUGH ANTI INFLAMMATORY, ANALGESIC, AND ANTIPYRETIC ACTIVITY
Salix PharmsRELISTORmethylnaltrexone bromideSOLUTION;SUBCUTANEOUS021964-003Sep 27, 2010RXYesYes► Subscribe► Subscribe► SubscribeYTREATMENT OF OPIOID-INDUCED CONSTIPATION
Salix Pharms IncRELISTORmethylnaltrexone bromideTABLET;ORAL208271-001Jul 19, 2016RXYesYes► Subscribe► Subscribe► SubscribeYTREATMENT OF OPIOID-INDUCED CONSTIPATION
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Moodys
Farmers Insurance
Queensland Health
Merck
Healthtrust
Accenture
Chinese Patent Office
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot